Skip to main content
Not Found
Digital Seminar

Respiratory Pharmacology: Pharmacokinetics, Indications for Use and Patient Monitoring


Speaker:
Paul Langlois, APN, PhD, CCRN, CCNS
Duration:
1 Hour 54 Minutes
Language:
Presented in EN, subtitles in EN and FR, handouts in EN and FR
Copyright:
May 19, 2022
Product Code:
POS078445
Media Type:
Digital Seminar


Description

Have you ever felt a lack of confidence when prescribing pulmonary medications?  You are not alone…   During this Summit session, Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, will take you through laboratory data, testing results and physical assessment findings to determine the appropriate respiratory diagnosis.  From there, you will take away the very latest updates to guide prescriptive decisions for the most common respiratory conditions you see in practice – asthma, COPD, COVID-19, TB, pulmonary hypertension, & pneumonia.  This jam-packed presentation is sure to leave you with new insights and evidence guidelines to support patients optimally.   

Credit

Program Information

Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.



**

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education, as well as which credit types are acceptable for continuing education hours. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. 
For other credit inquiries not specified below, please contact info@pesi.com or 800-844-8260 before purchase.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.


---

Earn up to 1.75 CE hours. Please see below, for more details, as credit amounts vary by state and profession. 


Pharmacology Nurse Practitioners

This self-study program offers 114 instructional minutes of pharmacology content which is designed to qualify for 1.75 contact hours toward your pharmacology requirement. 


Nurses, Nurse Practitioners, and Clinical Nurse Specialists - ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 1.75 contact hours. Expires: 05/20/2025.


California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 1.5 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.


Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 1.5 self-study contact hours.

CE Broker


Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 1.75 self-study contact hours. Please email cepesi@pesi.com with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.


Physicians

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. This activity was originally recorded on 05/19/2022. It was last reviewed on 05/04/2022 and is valid until 05/05/2025.

 

Physicians should only claim credit commensurate with the extent of their participation in the activity. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.


Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 1.5 hours for completing this self-study program. This activity was originally recorded on 05/19/2022. It was last reviewed on 05/04/2022 and is valid until 05/05/2025

 

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.


Other Professions

This self-study activity qualifies for 1.75 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.


Respiratory Care Practitioners
This program has been approved for 2.0 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063. Course #191610000 . Approval is good until 07/09/2025. Full attendance is required to receive a certificate of successful completion. You will need to provide your AARC Member Number to PESI.

Handouts

Speaker

Paul Langlois, APN, PhD, CCRN, CCNS's Profile

Paul Langlois, APN, PhD, CCRN, CCNS Related seminars and products


Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.

Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.

His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.  

 

Speaker Disclosures:
Financial: Paul Langlois has employment relationships with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Paul Langlois is a member of the American Nurses Association and the American Association of Critical Care Nurses.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.

For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com  


Questions?

Visit our FAQ page at https://www.pesicanada.ca/faq or contact us at https://www.pesicanada.ca/contact-us.


Objectives

  1. Determine the best medications to use during acute asthma attack. 
  2. Manage the current recommended medications for the COVID-19 patient both out- and in-patient. 
  3. Formulate a medication regimen for a tuberculosis patient, both newly diagnosed and with drug-resistant tuberculosis. 
  4. Devise the treatment protocol for a patient with pulmonary hypertension. 
  5. Plan for optimal antibiotic selection for the patient with bacterial pneumonia. 

Outline

Asthma – Not Just Bronchodilators Anymore 

  • How is asthma diagnosed? 
  • Global Initiative for Asthma (GINA) medication options 
  • Role of corticosteroids in asthma treatment 
  • Short acting beta agonists (SABA), long-acting beta agonists (LABA) - the difference and monitoring parameters 
  • Muscarinic antagonists, leukotriene modifiers and phosphodiesterase inhibitors - must know indications and contraindications  
  • Monoclonal antibodies for asthma relief 

Chronic Obstructive Pulmonary Disease (COPD) – Long Term Pharmacologic Therapies 

  • COPD causes, symptoms and diagnostic tests 
  • Non-pharmacologic treatments 
  • SABA and LABA - when and how much 
  • Inhaled corticosteroids alone or in combination with bronchodilators 
  • Vaccines are a must – which ones and at what age to administer 

SARS-CoV2, COVID-19 

  • Laboratory parameters for SARS-CoV2 
  • How effective are all those COVID-19 vaccines 
  • Which antiviral medications are FDA approved and which are still in clinical trials? 
  • Dexamethasone is effective - but only in certain patient populations 

Tuberculosis (TB): Still Prevalent and Highly Contagious 

  • What is Mycobacterium tuberculosis and how is it detected? 
  • First line medications for drug susceptible TB (doses, how often & how long to take) 
  • Multi-drug resistant TB treatments 

Pulmonary Hypertension 

  • Diagnosis of pulmonary hypertension  
  • 12-lead ECG results in a patient with pulmonary hypertension 
  • Select between calcium channel blockers, phosphodiesterase inhibitors, endothelin receptor antagonizes and prostacyclin agonists 

Pneumonia 

  • Community acquired treatment options 
  • Antibiotic options based on patient history 
  • Hospital acquired pharmacology 
  • How to treat methicillin resistant staphylococcus aureus

Target Audience

  • Nurses
  • Nurse Practitioners
  • Pharmacists
  • Physicians
  • Physician Assistants
  • Respiratory Therapists

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesicanada.com.

Please wait ...

Back to Top